Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 7, 2013; 19(33): 5485-5492
Published online Sep 7, 2013. doi: 10.3748/wjg.v19.i33.5485
Published online Sep 7, 2013. doi: 10.3748/wjg.v19.i33.5485
Figure 5 Propofol inhibits constitutively active nuclear factor-κB in MIA-PaCa-2 cells.
A: MIA-PaCa-2 cells were treated with 0, 10, 25, 50, or 100 μmol/mL propofol for 72 h and nuclear extracts were probed for nuclear factor-κB (NF-κB) binding to a DNA consensus sequence. Results of NF-κB DNA-binding activity by electrophoretic mobility shift assay (EMSA); B: MIA-PaCa-2 cells were treated with 100 μmol/mL propofol for 24, 48, or 72 h and nuclear extracts were probed for NF-κB binding to a DNA consensus sequence. Results of NF-κB DNA-binding activity by EMSA. Retinoblastoma protein in the nuclear extract was used as a loading control.
-
Citation: Du QH, Xu YB, Zhang MY, Yun P, He CY. Propofol induces apoptosis and increases gemcitabine sensitivity in pancreatic cancer cells
in vitro by inhibition of nuclear factor-κB activity. World J Gastroenterol 2013; 19(33): 5485-5492 - URL: https://www.wjgnet.com/1007-9327/full/v19/i33/5485.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i33.5485